### 5767 Federal Register / Vol. 75, No. 23 / Thursday, February 4, 2010 / Notices

requesting exporter accounts for a significant proportion of exports of the subject merchandise, and (3) no compelling reasons for denial exist, we are granting the request and are postponing the final determination until no later than 135 days after the publication of the preliminary determination notice in the Federal Register , or May 21, 2010. Further, in accordance with section 733(d) of the Act, suspension of liquidation will be extended accordingly. This postponement is issued and published in accordance with19 CFR 351.210(g).

Dated: January 28, 2010. Ronald K. Lorentzen, Deputy Assistant Secretary for Import Administration. [FR Doc. 2010–2316 Filed 2–3–10; 8:45 am]

**BILLING CODE 3510–DS–S**

**CONSUMER PRODUCT SAFETY COMMISSION** 
**All Terrain Vehicle Chinese Language Webinar; Meeting** 

**AGENCY :**  Consumer Product Safety Commission.

**ACTION :**  Notice.

The Consumer Product Safety Commission (CPSC) is announcing the following meeting: All Terrain Vehicle Chinese Language Webinar. The webinar will focus on CPSC’s requirements for ATV’s, including CPSC’s Action Plan and mandatory vehicle requirements.

Date and Time: The meeting will be held on February 4, 2010 at 6:00 am Eastern Standard Time.

Location: The meeting will be held live via webinar. Chinese language speakers can access the webinar at http://www.cpsc.gov/webcast/ index

_ ch.html. English speakers can access the webinar at http:// www.cpsc.gov/webcast/index.html.

Contact: Laurie Hopkins, International Programs Coordinator, Office of International Programs and Intergovernmental Affairs, Consumer Product Safety Commission, 4330 East West Highway, Suite 505–A, 301–504– 7797, FAX: 301–504–0137 e-mail: lhopkins@cpsc.gov.

Dated January 26, 2010. Todd A. Stevenson, Secretary of the Commission. [FR Doc. 2010–2072 Filed 2–3–10; 8:45 am]

**BILLING CODE 6355–01–M CONSUMER PRODUCT SAFETY**  **COMMISSION**
**Sunshine Act Meetings**

**TIME AND DATE :**  Wednesday, February 3, 2010, 2 p.m.–4 p.m.
**PLACE :**  Hearing Room 420, Bethesda Towers, 4330 East West Highway, Bethesda, Maryland.

**STATUS :**  Closed to the public.

**MATTER TO BE CONSIDERED :**  Compliance Weekly Report—Commission Briefing.

The staff will brief the Commission on various compliance matters.

For a recorded message containing the latest agenda information, call (301) 504–7948.
**CONTACT PERSON FOR MORE INFORMATION :**  Todd A. Stevenson, Office of the Secretary, U.S. Consumer Product Safety Commission, 4330 East West Highway, Bethesda, MD 20814 (301) 504–7923.

Dated January 26, 2010. Todd A. Stevenson, Secretary. [FR Doc. 2010–2068 Filed 2–3–10; 8:45 am]

**BILLING CODE 6355–01–M**

**DEPARTMENT OF DEFENSE**
**Office of the Secretary**
**Veterans’ Advisory Board on Dose Reconstruction; Meeting** 

**AGENCY :**  Defense Threat Reduction Agency, DoD.
**ACTION :**  Advisory board meeting notice.

**SUMMARY :**  Under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended) and the Sunshine in the Government Act of 1976 (5 U.S.C. 552b, as amended) the Defense Threat Reduction Agency (DTRA) and the Department of Veterans Affairs (VA) announce the following advisory board meeting of the Veterans’ Advisory Board on Dose Reconstruction (VBDR). The public is invited to attend.

**DATES :**  The meeting will be held on Thursday, March 4, 2010, from 8:30 a.m. to 11:45 a.m. and from 1:15 p.m. to 5 p.m. A public comment session is scheduled from 10:15 a.m. to 10:45 a.m.

**ADDRESSES :**  The meeting will be held at the Hilton Arlington Hotel, 950 North Stafford Street, Arlington, VA 22203.

**FOR FURTHER INFORMATION CONTACT :**  The Veterans’ Advisory Board on Dose Reconstruction Toll Free at 1–866–657– VBDR (8237).

Additional information may be found at http://vbdr.org.

**SUPPLEMENTARY INFORMATION :**  Purpose of Meeting To obtain, review and evaluate information related to the Board’s mission to provide guidance and oversight of the dose reconstruction and claims compensation programs for veterans of U.S.-sponsored atmospheric nuclear weapons tests from 1945–1962; veterans of the 1945–1946 occupation of Hiroshima and Nagasaki, Japan; and veterans who were prisoners of war in those regions at the conclusion of World War II. In addition, the advisory board will assist the VA and DTRA in communicating with the veterans. Meeting Agenda

The meeting will open with an introduction of the Board. After introductions, the following briefings will be presented: ‘‘Veterans Health Administration Procedures and the Ionizing Radiation Registry’’ by Victoria Cassano, M.D.; ‘‘Discussion on: Projecting Future Operations of VBDR at the Strategic Level (September 15, 2009 Draft) ’’ by Dr. John Lathrop; ‘‘Update on the NTPR Dose Reconstruction Program’’ by Dr. Paul Blake; and ‘‘Update on the VA Radiation Claims Compensation Program for Veterans ’’ by Mr. Brad Flohr. The morning session includes one half-hour open public comment session. In the afternoon, the four subcommittees established during the inaugural VBDR session will report on their activities since June 2009. The subcommittees are the ‘‘ Subcommittee on DTRA Dose Reconstruction Procedures, ’’ the ‘‘ Subcommittee on VA Claims Adjudication Procedures, ’’ the

‘‘ Subcommittee on Quality Management and VA Process Integration with DTRA Nuclear Test Personnel Review Program, ’’ and the ‘‘ Subcommittee on Communication and Outreach. ’’ The remainder of the meeting will be devoted to a discussion of the future of the VBDR. Meeting Accessibility

Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102–3.140 through 102–3.165, and the availability of space, this meeting is open to the public. Seating is limited by the size of the meeting room. All persons must sign in legibly at the registration desk.

Written Statements

Pursuant to 41 CFR 102–3.105(j) and 102–3.140(c), interested persons may submit a written statement for consideration by the Veterans’ Advisory Board on Dose Reconstruction. Written statements should be no longer than two type written pages and must address: The issue, discussion, and recommended course of action.